SANTINI, DAVIDE
 Distribuzione geografica
Continente #
AS - Asia 2.790
NA - Nord America 1.691
EU - Europa 1.060
AF - Africa 135
SA - Sud America 118
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.797
Nazione #
US - Stati Uniti d'America 1.661
VN - Vietnam 1.140
SG - Singapore 595
CN - Cina 515
IT - Italia 267
HK - Hong Kong 205
SE - Svezia 139
DE - Germania 129
GB - Regno Unito 97
KR - Corea 86
BR - Brasile 79
FR - Francia 78
FI - Finlandia 65
IN - India 65
NL - Olanda 54
IE - Irlanda 53
CI - Costa d'Avorio 49
CH - Svizzera 46
JP - Giappone 28
RU - Federazione Russa 28
AT - Austria 26
SC - Seychelles 26
TG - Togo 22
JO - Giordania 21
PH - Filippine 21
BG - Bulgaria 19
PL - Polonia 19
AR - Argentina 18
ID - Indonesia 17
CA - Canada 14
BD - Bangladesh 13
NG - Nigeria 13
TH - Thailandia 13
PK - Pakistan 11
TW - Taiwan 11
MX - Messico 10
ZA - Sudafrica 10
IQ - Iraq 9
SA - Arabia Saudita 9
TR - Turchia 9
UA - Ucraina 8
BE - Belgio 7
ES - Italia 7
CO - Colombia 5
EC - Ecuador 5
VE - Venezuela 5
LT - Lituania 4
OM - Oman 4
PY - Paraguay 4
UZ - Uzbekistan 4
TN - Tunisia 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AU - Australia 2
AZ - Azerbaigian 2
CL - Cile 2
CZ - Repubblica Ceca 2
EE - Estonia 2
ET - Etiopia 2
GE - Georgia 2
GR - Grecia 2
LB - Libano 2
ML - Mali 2
MU - Mauritius 2
NP - Nepal 2
PT - Portogallo 2
SN - Senegal 2
BA - Bosnia-Erzegovina 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
GH - Ghana 1
GM - Gambi 1
GT - Guatemala 1
IL - Israele 1
IR - Iran 1
JM - Giamaica 1
KE - Kenya 1
KH - Cambogia 1
MA - Marocco 1
MK - Macedonia 1
NI - Nicaragua 1
PS - Palestinian Territory 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 5.797
Città #
Singapore 395
Ho Chi Minh City 316
Hanoi 255
Ashburn 237
Hong Kong 187
San Jose 170
Hefei 146
Chandler 133
Santa Clara 100
Bologna 89
Fairfield 79
Seoul 74
Beijing 66
Los Angeles 66
Southend 66
Dallas 62
Da Nang 58
Dublin 53
Abidjan 49
Helsinki 47
Bern 46
Seattle 43
Boardman 42
Haiphong 41
New York 37
Houston 36
Woodbridge 35
Princeton 33
Council Bluffs 29
Lauterbourg 29
Cambridge 28
Munich 27
Tokyo 23
Turin 23
Lomé 22
Wilmington 22
Amman 21
Buffalo 21
Bến Tre 20
Biên Hòa 19
Sofia 19
Thái Nguyên 18
Redondo Beach 17
Vienna 17
Frankfurt am Main 15
Berlin 14
Can Tho 14
Florence 14
Shanghai 14
Bengaluru 13
Abeokuta 12
Falkenstein 12
Guangzhou 12
Redmond 12
Warsaw 12
Hải Dương 11
Milan 11
Orem 11
Quận Bình Thạnh 11
Bắc Ninh 10
Lappeenranta 10
Amsterdam 9
Chicago 9
Jakarta 9
Shenzhen 9
Vũng Tàu 9
Westminster 9
Ann Arbor 8
Bắc Giang 8
London 8
Nha Trang 8
Ninh Bình 8
Nuremberg 8
The Dalles 8
Thái Bình 8
Bremen 7
Brussels 7
Phoenix 7
Quận Một 7
São Paulo 7
Turku 7
Tân Tiến 7
Washington 7
Des Moines 6
Huế 6
Hyderabad 6
Mexico City 6
Montreal 6
Quận Bảy 6
Stockholm 6
Boston 5
Cao Lanh 5
Changsha 5
Chengdu 5
Denver 5
Ha Long 5
Jinan 5
New Taipei City 5
Phủ Lý 5
Qingdao 5
Totale 3.790
Nome #
Comparison of Pathological Scores for Predicting Metastasis in Pheochromocytoma and Paraganglioma: a Single-Center Experience. 331
Computerized tomography texture analysis of pheochromocytoma: relationship with hormonal and histopathological data 232
HPV DNA Associates With Breast Cancer Malignancy and It Is Transferred to Breast Cancer Stromal Cells by Extracellular Vesicles 218
Arid1a and ctnnb1/β-catenin molecular status affects the clinicopathologic features and prognosis of endometrial carcinoma: Implications for an improved surrogate molecular classification 216
Grade group system and plasma androgen receptor status in the first line treatment for metastatic castration resistant prostate cancer 206
Bone metastases in biliary cancers: A multicenter retrospective survey 198
Relevance of ARID1A Mutations in Endometrial Carcinomas 193
Incidental diagnosis of very small rectal neuroendocrine neoplasms: when should endoscopic submucosal dissection be performed? A single ENETS centre experience 183
A cure model survival analysis of patients affected by small intestinal neuroendocrine neoplasms: the Bologna ENETS center experience 181
Pancreatic ductal adenocarcinoma associated with autoimmune pancreatitis. 174
Health-related quality of life in patients with a germline BRCA mutation and metastatic pancreatic cancer receiving maintenance olaparib 170
HLA-J, a Non-Pseudogene as a New Prognostic Marker for Therapy Response and Survival in Breast Cancer 169
Radiologically defined lipid-poor adrenal adenomas: histopathological characteristics 167
A simple immunohistochemical bio-profile incorporating Bcl2 curbs those cases of invasive breast carcinoma for which an Oncotype Dx characterization is needed 164
Mesonephric-like adenocarcinomas of the ovary: pathological and molecular characterisation of a case series. 163
Large−Scale Profiling of Extracellular Vesicles Identified miR−625−5p as a Novel Biomarker of Immunotherapy Response in Advanced Non−Small−Cell Lung Cancer Patients 162
Prognostic evaluation in patients with advanced cancer in the last months of life: ESMO Clinical Practice Guideline ☆ 160
Atypical fibroxanthoma associated with differentiated-type vulvar intraepithelial neoplasia: Case report of an unusual entity 157
An exceptional case of primary ovarian angiosarcoma 155
Evolving knowledge in surgical oncology of pancreatic cancer: from theory to clinical practice—a fifteen-year journey at a tertiary referral centre 150
Bone health and body composition in prostate cancer: Meet-URO and AIOM consensus about prevention and management strategies 147
The Italian Rare Pancreatic Exocrine Cancer Initiative 145
A Novel Prognostic Tool in Western and Eastern Biliary Tract Cancer Patients Treated in First-line Setting: the ECSIPOT Index 128
What is the Outcome of Patients Affected by Intraductal Papillary Mucinous Neoplasms Without High-Risk Stigmata?: A Single-Center Retrospective Study 118
Prognostic Role of a New Index Tested in European and Korean Advanced Biliary Tract Cancer Patients: the PECS Index 118
Idiopathic myenteric ganglionitis underlying intractable vomiting in a young adult 111
CAR-T cell therapy: A potential new strategy against prostate cancer 100
A clinically applicable integrated molecular, immunohistochemical and histological approach for endometrial carcinoma. 99
Integrated histopathologic and molecular classification of endometri- al carcinoma: identification of prognostic subgroups 98
Testosterone levels and androgen receptor copy number variations in castration-resistant prostate cancer treated with abiraterone or enzalutamide 94
Prognostic Role of Systemic Inflammatory Indexes in Germ Cell Tumors Treated With High-Dose Chemotherapy 88
Role and relevance of quality indicators in the selection of first-line treatment of patients with metastatic renal cell carcinoma: A position paper of the MeetURO Group 83
Ovarian mixed malignant Brenner-mucinous tumour: report of a unique case 81
Prediction of survival with second-line therapy in biliary tract cancer: Actualisation of the AGEO CT2BIL cohort and European multicentre validations 78
Real-world experience and clinical impact of drug-drug interactions in HR+/HER2- advanced breast cancer patients treated with abemaciclib plus endocrine therapy: the AB-ITALY study 75
Risk stratification for pheochromocytoma and paraganglioma: a comparison of pathological scores for prediction of metastatic potential. 73
PATHOLOGICAL CHEMOTHERAPY RESPONSE SCORE IN TUBO-OVARIAN HIGH-GRADE SEROUS CARCINOMA: CLINICOPATHOLOGIC AND GENETIC FEATURES 71
The use of bone-modifying agents in early breast cancer: AIOM Guidelines update and perspectives 66
Functional stability, progression and evolution of targeted drug sensitivity of HER-2-positive breast cancer patient-derived xenografts 64
Factors predicting human papillomavirus clearance in cervical intraepithelial neoplasia lesions treated by conization 58
Pathological and immunohistochemical features of ovarian neuroendocrine tumor: a single center experience. 58
Lenvatinib in the management of metastatic renal cell carcinoma: a promising combination therapy? 55
Erratum: Microscopic margins of resection influence primary gastrointestinal stromal tumor survival (Onkologie (2012) 35 (645-648)) 38
Pathologic findings in risk-reducing salpingo-oophorectomy (RRSO) in women with BRCA1 or BRCA2 mutations: a single center experience. 36
Cabozantinib beyond progression improves survival in advanced renal cell carcinoma patients: the CABEYOND study (Meet-URO 21) 34
Role of Bone Metastases in Patients Receiving Immunotherapy for Pre-Treated Urothelial Carcinoma: The Multicentre, Retrospective Meet-URO-1 Bone Study 24
Targeted therapies for advanced bladder cancer: new strategies with FGFR inhibitors 13
Totale 5.902
Categoria #
all - tutte 17.633
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.633


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202182 0 0 0 0 0 0 0 0 0 13 12 57
2021/2022330 16 9 17 27 30 12 4 14 30 38 95 38
2022/2023669 36 62 28 63 75 66 21 41 143 23 41 70
2023/2024236 28 41 20 21 9 49 7 9 10 14 10 18
2024/20251.082 57 135 73 70 151 57 47 60 20 78 86 248
2025/20263.171 496 261 249 202 255 104 720 116 560 208 0 0
Totale 5.902